# Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block

> **NCT03700177** · PHASE4 · UNKNOWN · sponsor: **Medical University Innsbruck** · enrollment: 60 (estimated)

## Conditions studied

- Effect of Drugs
- Breast Pain
- Anesthesia, Local

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo
- **DRUG:** Ropivacaine Injection [Naropin]

## Key facts

- **NCT ID:** NCT03700177
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03700177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03700177, "Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03700177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*